U.S.-UK alliance targets the world's deadliest superbugs
Thursday, March 30, 2017 - 10:41
in Mathematics & Economics
LONDON (Reuters) - Eleven biotech companies and research teams in Britain and the United States were awarded up to $48 million in funding on Thursday to speed development of new antibiotics powerful enough to take on the world's deadliest superbugs.